BEECHFIELD MEDICAL CENTRE — All Prescriptions & Medications — Page 13
Practice Code: C83003 | SPALDING, PE11 1UN
Showing results 601-650 of 765
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ciprofibrate | 22 | 616 | £1.5K | +64.7% ▲ |
| Lacosamide | 22 | 1,960 | £179 | -59.1% ▼ |
| Testosterone esters | 22 | 22 | £48 | +49.2% ▲ |
| Combined ethinylestradiol 35mcg | 22 | 1,365 | £87 | +76.6% ▲ |
| Salicylic acid | 22 | 203 | £76 | +74.0% ▲ |
| Benzalkonium chloride | 22 | 6,250 | £137 | +91.8% ▲ |
| Other individually formulated bought in preparations | 22 | 662 | £123 | -32.7% ▼ |
| 22 | 226 | £877 | +85.5% ▲ | |
| 22 | 3,200 | £317 | -54.4% ▼ | |
| Olmesartan medoxomil/hydrochlorothiazide | 21 | 588 | £293 | +111.8% ▲ |
| Imipramine hydrochloride | 21 | 693 | £269 | -17.6% ▼ |
| Almotriptan | 21 | 120 | £256 | +69.4% ▲ |
| Biphasic insulin lispro | 21 | 260 | £1.6K | -51.1% ▼ |
| Glucagon | 21 | 34 | £1.4K | +38.0% ▲ |
| Cabergoline | 21 | 184 | £422 | +35.4% ▲ |
| Ready to serve 4.5 - 5 kcal/ml energy (fat) liquid (0913142) | 21 | 16.8K | £489 | +87.3% ▲ |
| Light liquid paraffin | 21 | 6,600 | £208 | -38.3% ▼ |
| Fludroxycortide | 21 | 49 | £1.5K | +99.2% ▲ |
| 21 | 161 | £661 | +249.5% ▲ | |
| 21 | 1,290 | £354 | +103.3% ▲ | |
| Sodium citrate (Rectal) | 20 | 282 | £181 | +44.9% ▲ |
| Propylthiouracil | 20 | 896 | £323 | +59.1% ▲ |
| Magnesium glycerophosphate | 20 | 1,678 | £604 | +45.6% ▲ |
| Ergocalciferol | 20 | 728 | £355 | +19.5% ▲ |
| Fusidic acid | 20 | 120 | £489 | +93.6% ▲ |
| Liquid paraffin | 20 | 11.0K | £112 | +188.3% ▲ |
| Clindamycin/tretinoin | 20 | 600 | £225 | +70.4% ▲ |
| Opicapone | 19 | 547 | £1.1K | -0.7% vs avg |
| Erythromycin ethylsuccinate | 19 | 2,500 | £264 | -18.6% ▼ |
| 19 | 152 | £336 | -21.6% ▼ | |
| 19 | 19 | £164 | +90.0% ▲ | |
| 19 | 930 | £2.0K | +34.3% ▲ | |
| Formoterol/glycopyrronium/budesonide | 18 | 18 | £761 | -70.1% ▼ |
| Indoramin | 18 | 1,140 | £1.0K | +18.4% ▲ |
| Ketorolac trometamol | 18 | 110 | £63 | +94.0% ▲ |
| Budesonide | 18 | 18 | £171 | +15.7% ▲ |
| 18 | 1,120 | £2.3K | -63.1% ▼ | |
| 18 | 42 | £3.3K | +149.9% ▲ | |
| 18 | 180 | £520 | +185.3% ▲ | |
| 18 | 2,400 | £345 | -43.3% ▼ | |
| 18 | 525 | £2.2K | -3.6% ▼ | |
| Amiloride hydrochloride | 17 | 287 | £144 | -32.5% ▼ |
| Lisinopril with diuretic | 17 | 476 | £168 | -17.1% ▼ |
| Flupentixol hydrochloride | 17 | 324 | £24 | -48.1% ▼ |
| Ethosuximide | 17 | 700 | £1.4K | +15.2% ▲ |
| Phased formulations of ethinylestradiol | 17 | 1,008 | £55 | +280.9% ▲ |
| Lodoxamide trometamol | 17 | 170 | £84 | +178.6% ▲ |
| Betaxolol | 17 | 170 | £62 | +78.8% ▲ |
| 17 | 9 | £83 | +358.1% ▲ | |
| Chlortalidone | 16 | 270 | £481 | +62.2% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.